1.Mengmeng Lu,Runpeng Han,Hao Yang,Lin Yang,Qiuchen Zhao,Jun Wang,Zhenyang Yu,Na Liu,Yangyang Xu,Fei Luo,Yitong Mu,Hao Wang,Fang Luo,Zhenyu Wang,Minjie Zhou,Kuozeng Lin,Hang Chen,Honglei Chen,Wei Zhou,Xiong Chen,Hanjie Li,Renjin Chen,Qing Zhang*,Li Wang*,Liang Cheng*. Homeostatic maturation programs drive human cDC2s into a tolerogenic state.Immunity. Available online 18 February 2026.IF 26.3
2.Shishuo Sun, Wanxin Zhao, Yibing Liang, Ying Xue, Qihong Li, Yifan Yuan, Zhenyu Wang, Xiaoge Gao, Yizhou Yao, Haiheng Xu, Hailong Li, Xiaoxiao Liu, Patrick Ming-Kuen Tang, Junnian Zheng,Qing Zhang*. HVEM costimulatory domain boosts CAR T cell efficacy against solid tumors via enhanced TRAF-mediated TNF signaling.Cell Commun Signal. 2026 Jan 8;24(1):90. doi: 10.1186/s12964-025-02648-4.IF 8.9
3.Shuai Yang, Jiawei Song, Zhenzhen Wang, Guang Peng, Linglin Tong, Xin Li1, Kexin Yang, Yang Chen, He Zhang,Qing Zhang*, Renjin Chen*. eIF6 deficiency alleviates colorectal cancer by modulating the gut microbiota and related metabolites.Cell Death Differ. 2026, doi: 10.1038/s41418-026-01674-0. Online ahead of print.IF 15.4
4.Shishuo Sun, Heng Xu, Wanxin Zhao, Qihong Li, Yifan Yuan, Guopeng Zhang, Shuyu Li, Bixi Wang, Wei Zhang, Xiaoge Gao, Junnian Zheng,Qing Zhang*. PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt/mTOR-mediated Ca2+ flux.Cancer Lett. 2024 Jan 28:581:216511.IF 9.7
5.Shishuo Sun, Chao Huang, Mengmeng Lu, Heng Xu, Yifan Yuan, Wanxin Zhao, Xiaolei Hu, Bixi Wang, Wei Zhang, Xiaoge Gao, Junnian Zheng, Lishan Su,Qing Zhang*. Herpes virus entry mediator costimulation signaling enhances CAR-T cell efficacy against solid tumors through metabolic reprogramming.Cancer Immunol Res. 2023, 11(4):515-529.IF 10.1
6.Chen Zhang, Lin Fang, Xueyan Wang, Sen Yuan, Wanjing Li, Weiping Tian, Jing Chen, Qi Zhang, Yuxin Zhang,Qing Zhang*, Junnian Zheng*. Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma.Mol Ther-Oncolytics. 2022, 24: 14-25.IF 7.2
7.Mengmeng Lu#, Xiaokang Zhang#, Bixi Wang, Shishuo Sun, Xiaoge Gao, Xiaohuan Wei, Xiaolei Hu, Chao Huang, Heng Xu, Wei Zhang, Zhen Li, Xinhui Feng, Junnian Zheng*,Qing Zhang*. Lenvatinib enhances T cell immunity and the efficacy of adoptive chimeric antigen receptor-modified T cells by decreasing myeloid-derived suppressor cells in cancer.Pharmacol Res. 2021, 174:105829.IF 10.334
8.Qing Zhang, Jiage Ding, Shishuo Sun, Hongyan Liu, Mengmeng Lu, Xiaohuan Wei, Xiaoge Gao, Xiaokang Zhang, Qiang Fu, Junnian Zheng.Aktinhibition at the initial stage of CAR-T preparation enhances the CAR-positive expression rate, memory phenotype and in vivo efficacy.Am J CancerRes. 2019, 9(11):2379-2396.IF 6.166
9.Jinwu Chen*, Xiaojie Li*, Ling Li*, Ting Zhang*,Qing Zhang*,Fangming Wu, Diyue Wang, Hongze Hu, Changlin Tian, Dongsheng Liao, Liang Zhao, Danxia Song, Yongyun Zhao, Chuanfang Wu, Xu Song.Coagulation factors VII, IX and X are antibacterial proteins against drug-resistant Gram-negative bacteria.Cell Research. 2019. 29(9):711-724.IF 25.617
10.Qing Zhang, Hongyan Liu, Hanhan Wang, Mengmeng Lu,Yangna Miao, Jiage Ding, Huizhong Li, Xiaoge Gao, Shishuo Sun, Junnian Zheng.Lenvatinib promotes antitumor immunity by enhancing the tumor infiltration and activation of NK cells.Am J CancerRes. 2019, 9(7):1382-1395.IF 6.166
